Comparing Cipla vs Torrent Pharmaceuticals? See the live Cipla and Torrent Pharmaceuticals share price on an interactive overlay chart from 1D to 5Y, with 52-week high/low, a full financials comparison (P&L, balance sheet and cash flow), shareholding pattern and support & resistance levels — everything you need to decide which stock is better to buy on the NSE and BSE.
This Cipla vs Torrent Pharmaceuticals comparison brings every key data point into one view, so you do not have to jump between two company pages. Here is what you can line up side by side:
There is no universal "better" stock — Cipla and Torrent Pharmaceuticals suit different investors. Work through the comparison in this order and pick the one whose profile matches your goals:
This page is a research tool for comparing Cipla and Torrent Pharmaceuticals and is not investment advice. Please do your own research or consult a SEBI-registered advisor before investing.
There is no single "better" stock — it depends on your goals, risk appetite and time horizon. This page compares Cipla and Torrent Pharmaceuticals side by side (live price, overlay chart, 52-week range, financials and shareholding), so you can judge which fits your strategy. As a rule of thumb, look at which company is growing revenue and profit faster, which carries less debt, and which has delivered steadier long-term returns.
Decide based on your own plan rather than a single tip. If you want steadier compounding, lean toward the company with consistent profit growth, lower borrowings and a stable promoter holding. If you can take more risk for higher upside, the faster-growing but more volatile stock may suit you. Use the price chart, returns and financials tables on this page to compare Cipla and Torrent Pharmaceuticals before deciding, and consult a SEBI-registered advisor if you are unsure.
Beyond the share price, Cipla and Torrent Pharmaceuticals differ in revenue scale, profit margins, debt levels, shareholding structure and how their stock has performed over 1, 3 and 5 years. The comparison tables on this page line up all of these metrics so the differences are easy to spot at a glance.
The overlay chart and Price Details table show the latest Cipla and Torrent Pharmaceuticals prices with today's change on a shared timeline, switchable across 1D, 5D, 1M, 6M, 1Y and 5Y, plus each stock's 52-week high and low.
For a long-term view, focus on the 3-year and 5-year performance, the multi-year revenue and profit trend, and balance-sheet strength rather than the latest price. The Historical Performance and Financials sections on this page let you compare Cipla and Torrent Pharmaceuticals over these longer horizons so you can match the choice to your investment timeframe.
Switch the comparison chart to its %-change view to see Cipla and Torrent Pharmaceuticals returns rebased on a shared timeline, and check the Historical Performance table for the 3M, 1Y, 3Y and 5Y moves in each stock. Past returns do not guarantee future performance, but they show how each stock has behaved through different market phases.
The Financials section compares Cipla vs Torrent Pharmaceuticals on revenue, EBITDA, profit, total assets, borrowings and reserves across recent years (P&L, balance sheet and cash flow), alongside their shareholding patterns — the core fundamentals behind any stock comparison.
Market capitalisation and PE ratio move with the live price, which you can track on the chart above. On this page you compare the drivers behind those ratios — revenue, profit, growth and debt for both Cipla and Torrent Pharmaceuticals — so you understand whether a higher valuation is justified by stronger fundamentals.
The Shareholding section charts promoter, FII, DII and public holdings for Cipla and Torrent Pharmaceuticals side by side. A high, stable promoter holding and rising institutional ownership are often read as signs of confidence, so this is a useful lens when comparing the two.
Dividend payouts depend on each company's profit and policy. Use the profit and reserves trend in the Financials section as a guide to dividend capacity for Cipla and Torrent Pharmaceuticals — a company with growing profits and healthy reserves is generally better placed to sustain and raise dividends.
Yes. Prices use NSE data with an automatic BSE fallback, so the Cipla vs Torrent Pharmaceuticals comparison works across both exchanges in a single view, with no separate lookup needed.
Work through the page top to bottom: compare the price and returns on the chart, the long-term performance table, then the financials (growth, profitability, debt) and shareholding. Pick the stock whose numbers and risk profile match your goals — and remember you can hold both for diversification. This page is a research tool, not investment advice.
Verify Cipla and Torrent Pharmaceuticals data and learn more at the official exchanges, the market regulator and trusted market-data sources: